NSABP B-30: definitive analysis of quality of life (QOL) and menstrual history (MH) outcomes from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.
Year: 2009
Type: conference-abstract
Source: Cancer Research
Institutions: University of California, Los Angeles, NSABP Foundation, UCLA Jonsson Comprehensive Cancer Center, University of Pittsburgh, Allegheny General Hospital, Kaiser Permanente, Kaiser Permanente Vallejo Medical Center, Kaiser Permanente San Diego Medical Center, Eastern Cooperative Oncology Group, Massachusetts General Hospital, University of Arizona, North Central Cancer Treatment Group, Mayo Clinic in Florida, Aultman Health Foundation, Washington Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2064572629